UBAC

Country: New Zealand

Language: English

Source: Ministry for Primary Industries

Active ingredient:

biofilm adhesion component of streptococcus uberis, strain 5616

Available from:

Hipra New Zealand Limited

Composition:

biofilm adhesion component of streptococcus uberis, strain 5616 0 vaccine

Therapeutic area:

Vaccine

Authorization date:

2023-03-02

Summary of Product characteristics

Batch:
Exp:
715458-20.2
INDICATION(S):
Subunit vaccine in emulsion for
injection that aids in the
prevention of clinical mastitis
associated with gram positive
bacteria in lactating dairy cows.
WITHHOLDING PERIOD:
Zero days.
ACVM No A011519
ONE DOSE (2 ML) CONTAINS:
LTA from BAC of
_S. uberis_
, strain
5616 Relative Potency Units ≥ 1
ROUTE OF ADMINISTRATION:
Intramuscular use.
Once opened use in 10 hours.
SUBUNIT VACCINE IN
EMULSION FOR INJECTION
1 DOSE
(2 ML)
Manufactured by:
LABORATORIOS HIPRA, S.A
.
Avda. la Selva, 135
17170 Amer (Girona) SPAIN
UBAC
FOR ANIMAL
TREATMENT ONLY
INDICATION(S):
Subunit vaccine in emulsion for
injection that aids in the prevention
of clinical mastitis associated with
gram positive bacteria in lactating
dairy cows.
WITHHOLDING PERIOD:
Zero days.
ACVM No. A011519
715463-20.2
ONE DOSE (2 ML) CONTAINS:
LTA from BAC of
_S. uberis_
, strain
5616 Relative Potency Units ≥ 1
ROUTE OF ADMINISTRATION:
Intramuscular use.
Once opened use in 10 hours.
Batch:
Exp:
SUBUNIT VACCINE IN EMULSION
FOR INJECTION
5 DOSES
(10 ML)
Manufactured by
LABORATORIOS HIPRA, S.A
.
Avda. la Selva, 135
17170 Amer (Girona) SPAIN
FOR ANIMAL TREATMENT ONLY
UBAC
_ _
SUBUNIT VACCINE IN EMULSION
FOR INJECTION
715467-20.2
ONE DOSE (2 ML) CONTAINS:
Lipoteichoic acid (LTA) from Biofilm Adhesion Component (BAC)
of
_Streptococcus uberis_
, strain 5616 ≥ 1 RPU*
*Relative Potency Units (ELISA).
TARGET SPECIES:
Dairy cows.
INDICATION(S):
Subunit vaccine in emulsion for injection that aids in the
prevention of clinical mastitis associated with gram
positive bacteria in lactating dairy cows.
Once opened use in 10 hours.
METHOD AND ROUTE OF ADMINISTRATION:
Intramuscular use. Read the package leaflet before use.
WITHHOLDING PERIOD:
Zero days.
Read the package leaflet before use.
Accidental injection is dangerous.
Store and transport refrigerated (2 ºC – 8 ºC). Protected from
light.
Do not freeze. Disposal: read the package leaflet.
Keep out of the sight and reach of children.
ACVM No. A011519
Manufatured by:
LABORATORIOS HIPR